Entero Healthcare Solutions Ltd Entero Healthcare Solutions disclosed on September 12, 2026, that its subsidiary ACE Cardiopathy Solutions Private Limited was levied a monetary penalty by the GST Authority in Uttar Pradesh.

The Office of Assistant Commissioner (Uttar Pradesh) imposed a penalty of ₹12,91,728 on ACE Cardiopathy for non-generation of E-Invoice. The order was received by the company on September 11, 2026.

Penalty Details and Payment

The company stated that the penalty amount has been paid under protest. This payment was made to secure the immediate release of a vehicle and to avoid further demurrage charges and operational losses associated with the detention of the asset.

Financial Impact and Next Steps

Entero Healthcare described the matter as pertaining to a subsidiary and noted that the amount involved is not material to the consolidated financial position, operations, or other activities of the listed entity.

The company indicated that ACE Cardiopathy shall pursue recovery or refund of the amount paid under protest through appropriate remedies available under the GST law. Necessary steps in this regard will be initiated in due course.

This disclosure was made pursuant to Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, read with Part A of Schedule III thereto.

Prasad Uno Family Trust acquired 10,88,500 equity shares of Entero Healthcare Solutions Ltd through a block deal on August 24, 2026. The transaction represents a 2.50% stake in the company’s total share capital.

The disclosure was filed with the Bombay Stock Exchange and the National Stock Exchange on August 26, 2026, under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Surbhi Singh, trustee of the trust, signed the filing.

Stake Movement Details

The acquisition increased the trust’s voting rights from 4.31% to 6.93% of the total share capital. In terms of diluted voting capital, the stake rose from 4.29% to 6.90%.

The company’s total equity share capital remained unchanged at INR 43,52,30,720, comprising 4,35,23,072 equity shares of face value INR 10 each. The total diluted share capital includes 1,95,890 shares underlying outstanding ESOPs.

Encumbrance Reduction

A notable shift occurred in the pledge status of the holdings. Before the transaction, the trust held 26,69,150 shares (6.13%) under encumbrance. Post-acquisition, the encumbered portion dropped to 4,40,500 shares (1.01%).

This reduction suggests a significant release of pledged shares or that the newly acquired shares were unencumbered, altering the risk profile of the trust’s overall position. The total holding including encumbrances stands at 34,55,420 shares (7.94% of total share capital).

What the Numbers Show

The divergence between the increase in free voting rights and the sharp decline in encumbered shares indicates a restructuring of the trust’s collateral base. While the economic exposure increased by 2.50%, the secured portion of the portfolio contracted by over 5 percentage points, potentially freeing up liquidity or reducing margin call risks for the acquirer.